These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 28972856)
1. Cardiac actin changes in the actomyosin interface have different effects on myosin duty ratio. Liu H; Henein M; Anillo M; Dawson JF Biochem Cell Biol; 2018 Feb; 96(1):26-31. PubMed ID: 28972856 [TBL] [Abstract][Full Text] [Related]
2. Do cardiac actin mutations lead to altered actomyosin interactions? Dahari M; Dawson JF Biochem Cell Biol; 2015 Aug; 93(4):330-4. PubMed ID: 26194323 [TBL] [Abstract][Full Text] [Related]
4. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. Olson TM; Doan TP; Kishimoto NY; Whitby FG; Ackerman MJ; Fananapazir L J Mol Cell Cardiol; 2000 Sep; 32(9):1687-94. PubMed ID: 10966831 [TBL] [Abstract][Full Text] [Related]
5. A Cardiomyopathy Mutation in the Myosin Essential Light Chain Alters Actomyosin Structure. Guhathakurta P; Prochniewicz E; Roopnarine O; Rohde JA; Thomas DD Biophys J; 2017 Jul; 113(1):91-100. PubMed ID: 28700929 [TBL] [Abstract][Full Text] [Related]
6. The effect of the Asp175Asn and Glu180Gly TPM1 mutations on actin-myosin interaction during the ATPase cycle. Rysev NA; Karpicheva OE; Redwood CS; Borovikov YS Biochim Biophys Acta; 2012 Feb; 1824(2):366-73. PubMed ID: 22155441 [TBL] [Abstract][Full Text] [Related]
7. Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy. Müller M; Mazur AJ; Behrmann E; Diensthuber RP; Radke MB; Qu Z; Littwitz C; Raunser S; Schoenenberger CA; Manstein DJ; Mannherz HG Cell Mol Life Sci; 2012 Oct; 69(20):3457-79. PubMed ID: 22643837 [TBL] [Abstract][Full Text] [Related]
8. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin. Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200 [TBL] [Abstract][Full Text] [Related]
9. Structural dynamics of the actin-myosin interface by site-directed spectroscopy. Korman VL; Anderson SE; Prochniewicz E; Titus MA; Thomas DD J Mol Biol; 2006 Mar; 356(5):1107-17. PubMed ID: 16406406 [TBL] [Abstract][Full Text] [Related]
10. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties. Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565 [TBL] [Abstract][Full Text] [Related]
11. Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner. Singh RR; McNamara JW; Sadayappan S J Biol Chem; 2021 Jul; 297(1):100836. PubMed ID: 34051236 [TBL] [Abstract][Full Text] [Related]
12. M-class hypertrophic cardiomyopathy cardiac actin mutations increase calcium sensitivity of regulated thin filaments. Teng GZ; Shaikh Z; Liu H; Dawson JF Biochem Biophys Res Commun; 2019 Oct; 519(1):148-152. PubMed ID: 31481237 [TBL] [Abstract][Full Text] [Related]
13. The myosin cardiac loop participates functionally in the actomyosin interaction. Ajtai K; Garamszegi SP; Watanabe S; Ikebe M; Burghardt TP J Biol Chem; 2004 May; 279(22):23415-21. PubMed ID: 15020589 [TBL] [Abstract][Full Text] [Related]
15. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin. Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968 [TBL] [Abstract][Full Text] [Related]
16. High-Resolution Cryo-EM Structure of the Cardiac Actomyosin Complex. Risi C; Schäfer LU; Belknap B; Pepper I; White HD; Schröder GF; Galkin VE Structure; 2021 Jan; 29(1):50-60.e4. PubMed ID: 33065066 [TBL] [Abstract][Full Text] [Related]
17. Actomyosin: law and order in motility. Volkmann N; Hanein D Curr Opin Cell Biol; 2000 Feb; 12(1):26-34. PubMed ID: 10679363 [TBL] [Abstract][Full Text] [Related]
18. Kinetic characterization of the function of myosin loop 4 in the actin-myosin interaction. Gyimesi M; Tsaturyan AK; Kellermayer MS; Málnási-Csizmadia A Biochemistry; 2008 Jan; 47(1):283-91. PubMed ID: 18067324 [TBL] [Abstract][Full Text] [Related]
19. The effect of genetically expressed cardiac titin fragments on in vitro actin motility. Li Q; Jin JP; Granzier HL Biophys J; 1995 Oct; 69(4):1508-18. PubMed ID: 8534821 [TBL] [Abstract][Full Text] [Related]
20. Omecamtiv Mecarbil Enhances the Duty Ratio of Human β-Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle. Swenson AM; Tang W; Blair CA; Fetrow CM; Unrath WC; Previs MJ; Campbell KS; Yengo CM J Biol Chem; 2017 Mar; 292(9):3768-3778. PubMed ID: 28082673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]